Beyond glycolysis: Hypoxia signaling as a master regulator of alternative metabolic pathways and the implications in clear cell renal cell carcinoma.

Cancer Letters
Zachary A Bacigalupa, W Kimryn Rathmell

Abstract

The relationship between kidney cancer, specifically clear cell renal cell carcinoma (ccRCC), and the hypoxia signaling program has been extensively characterized. Its underlying role as the primary driver of the disease has led to the development of the most effective targeted therapies to date. Cellular responses to hypoxia or mutations affecting the von Hippel-Lindau (VHL) tumor suppressor gene stabilize the hypoxia inducible factor (HIF) transcription factors which then orchestrate elaborate downstream signaling events resulting in adaptations to key biological processes, such as reprogramming metabolism. The direct link of hypoxia signaling to glucose uptake and glycolysis has long been appreciated; however, the HIF family of proteins directly regulate many downstream targets, including other transcription factors with their own extensive networks. In this review, we will summarize our current understanding of how hypoxia signaling regulates other metabolic pathways and how this contributes to the development and progression of clear cell renal cell carcinomas.

References

Jun 6, 1995·Proceedings of the National Academy of Sciences of the United States of America·G L WangG L Semenza
Feb 1, 1997·Kidney International·G L SemenzaA Yu
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Mar 10, 2001·Experimental Cell Research·K Kondo, W G Kaelin
Apr 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Steven J FreedmanMichael J Eck
Feb 24, 1956·Science·O WARBURG
May 4, 2004·Nature Reviews. Molecular Cell Biology·Christopher J Schofield, Peter J Ratcliffe
Jul 13, 2004·The Journal of Biological Chemistry·Rebecca J AppelhoffJonathan M Gleadle
Dec 21, 2005·The Journal of Nutrition·John T Brosnan, Margaret E Brosnan
Mar 7, 2006·Cell Metabolism·M Celeste Simon
Jan 9, 2007·Current Opinion in Genetics & Development·John D Gordan, M Celeste Simon
Oct 12, 2007·Nature Reviews. Molecular Cell Biology·Scott A Detmer, David C Chan
Dec 22, 2007·Expert Review of Anticancer Therapy·W Kimryn Rathmell, Shufen Chen
Oct 28, 2008·The International Journal of Biochemistry & Cell Biology·W Marston LinehanDonald P Bottaro
May 23, 2009·Science·Matthew G Vander HeidenCraig B Thompson
Jan 25, 2011·Nature Chemical Biology·Tracey M GlosterDavid J Vocadlo
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Apr 22, 2011·Nature Reviews. Cancer·Willem H KoppenolChi V Dang
Nov 22, 2011·Nature·Christian M MetalloGregory Stephanopoulos
Jun 19, 2013·Expert Review of Anticancer Therapy·Brian ShuchRamaprasad Srinivasan
Jun 25, 2013·Nature·UNKNOWN Cancer Genome Atlas Research Network
Jan 1, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian ShuchW Marston Linehan

❮ Previous
Next ❯

Citations

Oct 30, 2020·Cells·Chrysa FilippopoulouGeorgia Chachami
Dec 10, 2020·Cells·Ivanka JimenezFelipe Simon
Jul 31, 2021·Nature Reviews. Clinical Oncology·Dean C SingletonWilliam R Wilson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.